Publications by authors named "Akio Murase"

Claim this Profile
D
Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs.
Shigeo Hayashi, Naomi Ueno, Akio Murase, Junji Takada

J Enzyme Inhib Med Chem· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
Shigeo Hayashi, Naomi Ueno, Akio Murase, Yoko Nakagawa, Junji Takada

Eur J Med Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Shigeo Hayashi, Yoko Sumi, Naomi Ueno, Akio Murase, Junji Takada

Biochem Pharmacol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of binding affinity of CJ-023,423 for human prostanoid EP4 receptor.
Akio Murase, Kazunari Nakao, Junji Takada

Pharmacology· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis.
Takako Okumura, Yoko Murata, Kana Taniguchi, Akio Murase, Aisuke Nii

J Pharm Pharmacol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation.
Akio Murase, Takako Okumura, Ayano Sakakibara, Hiroko Tonai-Kachi, Kazunari Nakao

Eur J Pharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.
Akio Murase, Yasuhito Taniguchi, Hiroko Tonai-Kachi, Kazunari Nakao, Junji Takada

Life Sci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties.
Kazunari Nakao, Akio Murase, Hiroyuki Ohshiro, Takako Okumura, Kana Taniguchi

J Pharmacol Exp Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor.
Takako Okumura, Yoko Murata, Masanori Hizue, Tomomi Matsuura, Rie Naganeo, Akio Murase

Eur J Pharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis